Lin, Xiao-Wen
Chen, Hao
Xie, Xiu-Ying
Liu, Can-Tong
Lin, Yi-Wei
Xu, Yi-Wei
Wang, Xin-Jia
Wu, Fang-Cai
Funding for this research was provided by:
Science and Technology Special Fund of Guangdong Province of China (STKJ202209069)
Guangdong Basic and Applied Basic Research Foundation Enterprise Joint Foundation (2022A1515220116)
Guangdong Basic and Applied Basic Research Foundation Enterprise Joint Foundation (2022A1515220180)
Guangdong Basic and Applied Basic Research Foundation Enterprise Joint Foundation (2022A1515220182)
Youth Research Fund Project of Cancer Hospital of Shantou University Medical College (2023A005)
Guangdong Esophageal Cancer Institute Science and Technology Program (M202224)
2020 Li Ka Shing Foundation Cross-Disciplinary Research Project Fund (2020LKSFG01B)
2020 Li Ka Shing Foundation Cross-Disciplinary Research Project Fund (2020LKSFG01D)
Guangdong Medical Science and Technology Research Program (A2023414)
Article History
Received: 5 June 2023
Accepted: 25 October 2023
First Online: 13 November 2023
Change Date: 8 June 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s13304-024-01904-5
Declarations
:
: The authors declare that they have no conflict of interest.
: This study was approved by the Hospital Ethics Committee in Sun Yat-Sen University Cancer Center (B2022-329-01), and individual informed consent for this retrospective analysis was waived. All work was performed in accordance with the principles of the Helsinki Declaration.
: Our nomogram was constructed based on pretreatment serological hepatic and renal function tests, which are required for every patient after admission. The clinical laboratory indicators are easily accessed, and do not increase the financial and physical burden on patients. This study was approved by the Ethics Committee in Sun Yat-Sen University Cancer Center (B2022-329-01). The requirement for informed consent from patients was waived because of its retrospective design.